Advancing allergy and asthma research to support improvements in human health is more critical than ever, as the rate of life-limiting cases are on the rise. New innovations and scientific breakthroughs are being discovered at a breakneck speed—but conducting the research is complex and multifaceted. One of the biggest challenges is finding a dedicated allergen partner with the knowledge and know-how to fully support your ongoing efforts and help advance your research.

For decades, InBio has worked in partnership with leading allergists, immunologists, academic and government researchers in the US, Europe, Asia, South America and Australasia.

Our ELISA 2.0 and MARIA® kits have been used to assess allergen exposure in epidemiologic studies of asthma carried out by the U.S. National Institutes of Health, the Centers for Disease Control and Prevention, the Department of Housing and Urban Development, and the Food and Drug Administration. InBio products have also been used in the European Union CREATE project on allergen standardization, in the European Community Respiratory Health Survey and in several large birth cohort studies at academic medical centers and universities throughout Europe.

InBio places a strong emphasis on ongoing scientific research and active collaborations with research groups in academia and industry. Our purified allergen products are used by many scientists for allergy and immunology research, including in mouse models of allergic inflammation and asthma.